BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9740134)

  • 1. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: introduction.
    Brandt JT
    Arch Pathol Lab Med; 1998 Sep; 122(9):765-6. PubMed ID: 9740134
    [No Abstract]   [Full Text] [Related]  

  • 2. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
    Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
    Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
    Olson JD; Arkin CF; Brandt JT; Cunningham MT; Giles A; Koepke JA; Witte DL
    Arch Pathol Lab Med; 1998 Sep; 122(9):782-98. PubMed ID: 9740136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of coagulation during treatment with direct oral anticoagulants].
    Kasper A; Lindhoff-Last E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1997-2000. PubMed ID: 24065404
    [No Abstract]   [Full Text] [Related]  

  • 5. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
    Laposata M; Green D; Van Cott EM; Barrowcliffe TW; Goodnight SH; Sosolik RC
    Arch Pathol Lab Med; 1998 Sep; 122(9):799-807. PubMed ID: 9740137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory testing of anticoagulants: the present and the future.
    Favaloro EJ; Lippi G; Koutts J
    Pathology; 2011 Dec; 43(7):682-92. PubMed ID: 22081129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescription and monitoring of anticoagulant therapies].
    Laviolle B; Oger E
    Rev Prat; 2008 Nov; 58(18):2063-70. PubMed ID: 19143281
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. College of American Pathologists Conference XXVIII on alternate site testing: keynote address. Reflections on a C major scale.
    Woodruff KH
    Arch Pathol Lab Med; 1995 Oct; 119(10):876. PubMed ID: 7487380
    [No Abstract]   [Full Text] [Related]  

  • 12. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
    Casimire T; Carter R; Peters S; Tweedle J; Charles KS
    Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendation for the introduction of the International Normalized Ratio as an objective measure for the dosage of oral anticoagulant therapy].
    Horstkotte D; Hohnloser S; Keller F; Kolde HJ; Müller-Beissenhirtz W; Taborski U; Webering F
    Z Kardiol; 1994 Sep; 83(9):676-9. PubMed ID: 7801672
    [No Abstract]   [Full Text] [Related]  

  • 14. College of American Pathologists Conference XXVIII on alternate site testing: introduction.
    Handorf CR
    Arch Pathol Lab Med; 1995 Oct; 119(10):867-73. PubMed ID: 7487378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current considerations in the use of the APTT in monitoring unfractionated heparin.
    Nelson DE
    Clin Lab Sci; 1999; 12(6):359-64. PubMed ID: 10724634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ximelagatran, a new oral anticoagulant--how will it affect laboratory practice? A clinical perspective.
    Machin SJ
    Lab Hematol; 2004; 10(3):172-3. PubMed ID: 15529439
    [No Abstract]   [Full Text] [Related]  

  • 17. When should low-molecular-weight heparin be monitored?
    Fairweather RB
    CAP Today; 1999 Jul; 13(7):48-50. PubMed ID: 10558049
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulant therapy. What to consider in practical management.
    McPherson ML; Grace KA
    Adv Nurse Pract; 1997 May; 5(5):32-4, 37-9. PubMed ID: 9459911
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation monitoring.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):283-304. PubMed ID: 19665679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring anticoagulant therapy by measuring haemostatic parameters.
    Chek JB
    East Afr Med J; 1997 Jan; 74(1):1-2. PubMed ID: 9145566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.